The great pharmaceutical-academic merger As drug companies fret over their finances, they are increasingly partnering with universities to help with early-stage research by Benjamin Plackett ...

The pharmaceutical industry is vital to human health, but it also has a significant environmental impact. It contributes up to 19% of Australia's health care sector's greenhouse gas (GHG ...

Market OutlineThe Global Pharmaceutical Manufacturing Market is valued at USD 576.54 Billion in 2024 and is projected to ...

Pharmaceutical market research analysis (PMRA) can validate a product's potential reach and market penetration capabilities. Investors use it to put a value on drug-making companies and their ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

--NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has signed a joint research agreement, together ...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

The Tax Cuts and Jobs Act (TCJA) has substantially reduced the domestic tax paid by American pharmaceutical giants.

The company also plans to establish a biomedical research innovation hub in San Diego, which will be its second global R&D hub in the US.

At the time, though experts said it was a watershed moment for Chinese pharmaceutical companies, it was little noticed outside the industry.

Seeking more efficient drug development, pharmaceutical giants and startups are encouraging AI fluency and in some cases offering training for it.

The pharmaceutical industry is vital to human health, but it also has a significant environmental impact.